Challenges in managing genetic cancer risk: a long-term qualitative study of unaffected women carrying BRCA1/BRCA2 mutations

被引:15
作者
Caiata-Zufferey, Maria [1 ]
Pagani, Olivia [2 ]
Cina, Viviane [3 ]
Membrez, Veronique [4 ]
Taborelli, Monica [2 ]
Unger, Sheila [3 ]
Murphy, Anne [5 ]
Monnerat, Christian [6 ]
Chappuis, Pierre O. [4 ,5 ,7 ]
机构
[1] Univ Geneva, Dept Sociol, Geneva, Switzerland
[2] Inst Oncol Southern Switzerland, Oncogenet & Breast Unit, Viganello, Switzerland
[3] CHU Vaudois, Serv Med Genet, CH-1011 Lausanne, Switzerland
[4] Hop Valais, Div Med Genet, Inst Cent, Sion, Switzerland
[5] Univ Hosp Geneva, Div Oncol, Oncogenet & Canc Prevent Unit, Geneva, Switzerland
[6] Hop Jura Delemont, Serv Oncol, Delemont, Switzerland
[7] Univ Hosp Geneva, Div Genet Med, Geneva, Switzerland
基金
瑞士国家科学基金会;
关键词
BRCA1/BRCA2; challenges; preventive medicine; qualitative research; risk management; CLINICAL-PRACTICE GUIDELINES; PSYCHOLOGICAL IMPACT; BRCA2; MUTATIONS; BREAST; GENOMICS; SURGERY;
D O I
10.1038/gim.2014.183
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Purpose: Women carrying BRCA1/BRCA2 germ-line mutations have an increased risk of developing breast/ovarian cancer. To minimize this risk, international guidelines recommend lifelong surveillance and preventive measures. This study explores the challenges that unaffected women genetically predisposed to breast/ovarian cancer face in managing their risk over time and the psychosocial processes behind these challenges. Methods: Between 2011 and 2013, biographical qualitative interviews were conducted in Switzerland with 32 unaffected French-and Italian-speaking women carrying BRCA1/BRCA2 mutations. Their mutation status had been known for at least 3 years (mean, 6 years). Data were analyzed through constant comparative analysis using software for qualitative analysis. Results: From the time these women received their positive genetic test results, they were encouraged to follow medical guidelines. Meanwhile, their adherence to these guidelines was constantly questioned by their social and medical environments. As a result of these contradictory pressures, BRCA1/BRCA2 mutation carriers experienced a sense of disorientation about the most appropriate way of dealing with genetic risk. Conclusion: Given the contradictory attitudes of health-care professionals in caring for unaffected BRCA1/BRCA2 mutation carriers, there is an urgent need to educate physicians in dealing with genetically at-risk women and to promote a shared representation of this condition among them.
引用
收藏
页码:726 / 732
页数:7
相关论文
共 36 条
  • [1] [Anonymous], 2009, Obstet Gynecol, V113, P957, DOI 10.1097/AOG.0b013e3181a106d4
  • [2] [Anonymous], 2005, BMJ-BRIT MED J
  • [3] Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history:: A combined analysis of 22 studies
    Antoniou, A
    Pharoah, PDP
    Narod, S
    Risch, HA
    Eyfjord, JE
    Hopper, JL
    Loman, N
    Olsson, H
    Johannsson, O
    Borg, Å
    Pasini, B
    Radice, P
    Manoukian, S
    Eccles, DM
    Tang, N
    Olah, E
    Anton-Culver, H
    Warner, E
    Lubinski, J
    Gronwald, J
    Gorski, B
    Tulinius, H
    Thorlacius, S
    Eerola, H
    Nevanlinna, H
    Syrjäkoski, K
    Kallioniemi, OP
    Thompson, D
    Evans, C
    Peto, J
    Lalloo, F
    Evans, DG
    Easton, DF
    [J]. AMERICAN JOURNAL OF HUMAN GENETICS, 2003, 72 (05) : 1117 - 1130
  • [4] BRCA in breast cancer: ESMO Clinical Practice Guidelines
    Balmana, J.
    Diez, O.
    Rubio, I. T.
    Cardoso, F.
    [J]. ANNALS OF ONCOLOGY, 2011, 22 : vi31 - vi34
  • [5] Awareness and Utilization of BRCA1/2 Testing Among US Primary Care Physicians
    Bellcross, Cecelia A.
    Kolor, Katherine
    Goddard, Katrina A. B.
    Coates, Ralph J.
    Reyes, Michele
    Khoury, Muin J.
    [J]. AMERICAN JOURNAL OF PREVENTIVE MEDICINE, 2011, 40 (01) : 61 - 66
  • [6] Bertaux D., 1981, BIOGRAPHY SOC LIFE H, DOI DOI 10.1093/OHR/10.1.154
  • [7] Why don't physicians follow clinical practice guidelines? A framewouk for improvement
    Cabana, MD
    Rand, CS
    Powe, NR
    Wu, AW
    Wilson, MH
    Abboud, PAC
    Rubin, HR
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 282 (15): : 1458 - 1465
  • [8] Meta-analysis of BRCA1 and BRCA2 penetrance
    Chen, Sining
    Parmigiani, Giovanni
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (11) : 1329 - 1333
  • [9] Predictive testing for hereditary non-polyposis colorectal cancer: motivation, illness representations and short-term psychological impact
    Claes, E
    Denayer, L
    Evers-Kiebooms, G
    Boogaerts, A
    Legius, E
    [J]. PATIENT EDUCATION AND COUNSELING, 2004, 55 (02) : 265 - 274
  • [10] Clarke A., 1997, Genetics, society and clinical practice, P179